Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Nov;116(6):2764–2770. doi: 10.1111/j.1476-5381.1995.tb17239.x

Structure-activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion.

G P Connolly 1, P J Harrison 1
PMCID: PMC1909137  PMID: 8591002

Abstract

1. The effects of pyrimidines and purines on the d.c. potential of the rat isolated superior cervical ganglion (SCG) have been examined by a grease-gap technique to determine the structure-activity requirements of the receptor activated by pyrimidines, i.e. a pyrimidinoceptor. 2. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl (ZTP), the pyrimidines, cytidine 5'-triphosphate (CTP), uridine 5'-triphosphate (UTP) and thymidine 5'-triphosphate (TTP) and the purines, adenosine 5'-triphosphate (ATP; in the presence of an A1-purinoceptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (1 microM)), adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S), guanosine 5'-triphosphate (GTP), inosine 5'-triphosphate (1TP) depolarized ganglia in a concentration-dependent manner. The relative order of ZTP and purine 5'-triphosphates in depolarizing ganglia was ZTP > or = ATP gamma S > > ATP > or = ITP = GTP, and for the pyrimidine 5'-triphosphates UTP > TTP > or = CTP. Depolarizations evoked by ATP gamma S were followed by concentration-dependent hyperpolarizations at 100 and 1000 microM. 3. At concentrations of between 0.1 microM and 1 mM, uridine 5'-diphosphate (UDP), uridine 5'-diphosphoglucose (UDPG) and uridine 5'-diphosphoglucuronic acid (UDPGA) evoked significant and concentration-dependent depolarizations, whereas uridine 5'-monophosphate (UMP), uridine and uracil were inactive or produced small (< 45 microV) depolarizations. The relative order of potency of uridine analogues in depolarizing ganglia was UDP > or = UTP > UDPG > UDPGA > > uracil > or = UMP = pseudouridine > or = uridine. At 3 and 10 mM, uridine produced concentration-dependent hyperpolarizations. Nikkomycin Z, a nucleoside resembling UTP (viz. the triphosphate chain at the 5'-position on the ribose moiety being replaced by a peptide), was inactive between 1 microM and 1 mM. Generally, a concentration of 10 mM was required before thymidine, 6-azathymine, 6-azauracil or 6-azauridine depolarized ganglia. 4. Suramin (300 microM), a P2-purinoceptor antagonist, significantly depressed depolarizations evoked by alpha, beta-methylene-ATP (alpha, beta-MeATP; 100 microM), ATP gamma S (100 microM), CTP (1 mM), GTP (1 mM), ZTP (30 microM) and ATP (300 microM) in the presence of DPCPX (1 microM). Suramin reversed a small depolarization evoked by UMP (1 mM) into a small hyperpolarization. In contrast depolarizations evoked by UDP, UTP, UDPG (all at 100 microM) and TTP (300 microM) were unaltered or enhanced by suramin. 5. It is concluded that the rat SCG contains distinct nucleotide receptors including a P2-purinoceptor (activated by alpha, beta-MeATP, ATP, GTP, ITP and ZTP) and a pyrimidinoceptor (activated by UTP, UDP, UDPG, UDPGA and TTP). The pyrimidinoceptor on rat SCG neurones had specific structure activity requirements with the di- and triphosphates of uridine being the most effective depolarizing agonists examined.

Full text

PDF
2764

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bischoff E., Tran-Thi T. A., Decker K. F. Nucleotide pyrophosphatase of rat liver. A comparative study on the enzymes solubilized and purified from plasma membrane and endoplasmic reticulum. Eur J Biochem. 1975 Feb 21;51(2):353–361. doi: 10.1111/j.1432-1033.1975.tb03935.x. [DOI] [PubMed] [Google Scholar]
  2. Brown H. A., Lazarowski E. R., Boucher R. C., Harden T. K. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells. Mol Pharmacol. 1991 Nov;40(5):648–655. [PubMed] [Google Scholar]
  3. Bruns R. F., Fergus J. H., Badger E. W., Bristol J. A., Santay L. A., Hartman J. D., Hays S. J., Huang C. C. Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):59–63. doi: 10.1007/BF00165037. [DOI] [PubMed] [Google Scholar]
  4. Connolly G. P. Differentiation by pyridoxal 5-phosphate, PPADS and IsoPPADS between responses mediated by UTP and those evoked by alpha, beta-methylene-ATP on rat sympathetic ganglia. Br J Pharmacol. 1995 Feb;114(3):727–731. doi: 10.1111/j.1476-5381.1995.tb17199.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Connolly G. P. Evidence from desensitization studies for distinct receptors for ATP and UTP on the rat superior cervical ganglion. Br J Pharmacol. 1994 Jun;112(2):357–359. doi: 10.1111/j.1476-5381.1994.tb13079.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Connolly G. P., Harrison P. J. Reactive blue 2 discriminates between responses mediated by UTP and those evoked by ATP or alpha,beta-methylene-ATP on rat sympathetic ganglia. Eur J Pharmacol. 1994 Jun 23;259(1):95–99. doi: 10.1016/0014-2999(94)90165-1. [DOI] [PubMed] [Google Scholar]
  7. Connolly G. P., Harrison P. J., Stone T. W. Action of purine and pyrimidine nucleotides on the rat superior cervical ganglion. Br J Pharmacol. 1993 Dec;110(4):1297–1304. doi: 10.1111/j.1476-5381.1993.tb13959.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Connolly G. P., Stone T. W., Brown F. Characterization of the adenosine receptors of the rat superior cervical ganglion. Br J Pharmacol. 1993 Oct;110(2):854–860. doi: 10.1111/j.1476-5381.1993.tb13891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Connolly G. P., Stone T. W. Ionic mechanism of action of adenosine on the rat superior cervical ganglion. J Auton Pharmacol. 1993 Aug;13(4):291–302. doi: 10.1111/j.1474-8673.1993.tb00277.x. [DOI] [PubMed] [Google Scholar]
  10. Crack B. E., Beukers M. W., McKechnie K. C., Ijzerman A. P., Leff P. Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands. Br J Pharmacol. 1994 Dec;113(4):1432–1438. doi: 10.1111/j.1476-5381.1994.tb17157.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dunn P. M., Blakeley A. G. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol. 1988 Feb;93(2):243–245. doi: 10.1111/j.1476-5381.1988.tb11427.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fine J., Cole P., Davidson J. S. Extracellular nucleotides stimulate receptor-mediated calcium mobilization and inositol phosphate production in human fibroblasts. Biochem J. 1989 Oct 15;263(2):371–376. doi: 10.1042/bj2630371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gerrits G. P., Monnens L. A., De Abreu R. A., Schröder C. H., Trijbels J. M., Gabreëls F. J. Disturbances of cerebral purine and pyrimidine metabolism in young children with chronic renal failure. Nephron. 1991;58(3):310–314. doi: 10.1159/000186442. [DOI] [PubMed] [Google Scholar]
  14. Gruol D. L., Siggins G. R., Padjen A. L., Forman D. S. Explant cultures of adult amphibian sympathetic ganglia: electrophysiological and pharmacological investigation of neurotransmitter and nucleotide action. Brain Res. 1981 Oct 26;223(1):81–106. doi: 10.1016/0006-8993(81)90808-8. [DOI] [PubMed] [Google Scholar]
  15. Hourani S. M., Chown J. A. The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder. Gen Pharmacol. 1989;20(4):413–416. doi: 10.1016/0306-3623(89)90188-2. [DOI] [PubMed] [Google Scholar]
  16. Häussinger D., Stehle T., Gerok W. Actions of extracellular UTP and ATP in perfused rat liver. A comparative study. Eur J Biochem. 1987 Aug 17;167(1):65–71. doi: 10.1111/j.1432-1033.1987.tb13304.x. [DOI] [PubMed] [Google Scholar]
  17. Jaeken J., Van den Berghe G. An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. Lancet. 1984 Nov 10;2(8411):1058–1061. [PubMed] [Google Scholar]
  18. Lukacsko P., Krell R. D. Response of the guinea-pig urinary bladder to purine and pyrimidine nucleotides. Eur J Pharmacol. 1982 Jun 4;80(4):401–406. doi: 10.1016/0014-2999(82)90086-3. [DOI] [PubMed] [Google Scholar]
  19. Nakazawa K. ATP-activated current and its interaction with acetylcholine-activated current in rat sympathetic neurons. J Neurosci. 1994 Feb;14(2):740–750. doi: 10.1523/JNEUROSCI.14-02-00740.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. O'Connor S. E., Dainty I. A., Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci. 1991 Apr;12(4):137–141. doi: 10.1016/0165-6147(91)90530-6. [DOI] [PubMed] [Google Scholar]
  21. Phillis J. W., Kirkpatrick J. R. The actions of adenosine and various nucleosides and nucleotides on the isolated toad spinal cord. Gen Pharmacol. 1978;9(4):239–247. doi: 10.1016/0306-3623(78)90043-5. [DOI] [PubMed] [Google Scholar]
  22. Ralevic V., Burnstock G. Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res. 1991 Dec;69(6):1583–1590. doi: 10.1161/01.res.69.6.1583. [DOI] [PubMed] [Google Scholar]
  23. Sakai K., Akima M., Matsushita H. Femoral vascular responses to purine and pyrimidine derivatives: release of 5-hydroxytryptamine by purine derivatives in isolated, cross-circulated rat hindlimb. Jpn J Pharmacol. 1979 Apr;29(2):243–251. doi: 10.1254/jjp.29.243. [DOI] [PubMed] [Google Scholar]
  24. Seifert R., Burde R., Schultz G. Activation of NADPH oxidase by purine and pyrimidine nucleotides involves G proteins and is potentiated by chemotactic peptides. Biochem J. 1989 May 1;259(3):813–819. doi: 10.1042/bj2590813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Seifert R., Schultz G. Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmacol Sci. 1989 Sep;10(9):365–369. doi: 10.1016/0165-6147(89)90009-6. [DOI] [PubMed] [Google Scholar]
  26. Seifert R., Wenzel K., Eckstein F., Schultz G. Purine and pyrimidine nucleotides potentiate activation of NADPH oxidase and degranulation by chemotactic peptides and induce aggregation of human neutrophils via G proteins. Eur J Biochem. 1989 Apr 15;181(1):277–285. doi: 10.1111/j.1432-1033.1989.tb14722.x. [DOI] [PubMed] [Google Scholar]
  27. Sidi Y., Mitchell B. S. Z-nucleotide accumulation in erythrocytes from Lesch-Nyhan patients. J Clin Invest. 1985 Dec;76(6):2416–2419. doi: 10.1172/JCI112255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Urquilla P. R., Van Dyke K., Trush M. Structure-activity relation of pyrimidine nucleotides and nucleoside in canine isolated cerebral vessels. J Pharm Pharmacol. 1978 Mar;30(3):189–190. doi: 10.1111/j.2042-7158.1978.tb13197.x. [DOI] [PubMed] [Google Scholar]
  29. den Hertog A., Nelemans A., Van den Akker J. The inhibitory action of suramin on the P2-purinoceptor response in smooth muscle cells of guinea-pig taenia caeci. Eur J Pharmacol. 1989 Aug 3;166(3):531–534. doi: 10.1016/0014-2999(89)90370-1. [DOI] [PubMed] [Google Scholar]
  30. von Kügelgen I., Häussinger D., Starke K. Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):556–560. doi: 10.1007/BF00169313. [DOI] [PubMed] [Google Scholar]
  31. von Kügelgen I., Starke K. Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jun;341(6):538–546. doi: 10.1007/BF00171734. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES